Biobeat Medical Smart Revenue and Competitors

Tel Aviv, Israel

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Biobeat Medical Smart's estimated annual revenue is currently $10M per year.(i)
  • Biobeat Medical Smart's estimated revenue per employee is $251,000

Employee Data

  • Biobeat Medical Smart has 40 Employees.(i)
  • Biobeat Medical Smart grew their employee count by 8% last year.

Biobeat Medical Smart's People

NameTitleEmail/Phone
1
Co-Founder and VP R&DReveal Email/Phone
2
VP R&DReveal Email/Phone
3
Director Strategic PartnershipsReveal Email/Phone
4
Operation & Customer Success ManagerReveal Email/Phone
5
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$21.1M840%N/AN/A
#2
$5.6M450%$91.1MN/A
#3
$202.8M577-2%$632.9MN/A
#4
$21.3M85-29%$99.9MN/A
#5
$21.1M842%$128MN/A
#6
$22.3M891%N/AN/A
#7
$6.8M27-4%N/AN/A
#8
$5.8M23-12%N/AN/A
#9
$3.3M130%N/AN/A
#10
$1.3M50%N/AN/A
Add Company

What Is Biobeat Medical Smart?

Biobeat is a med-tech company with unique health-AI abilities in the patient monitoring space. The company's remote patient monitoring (RPM) health-AI platform includes a disposable short-term chest-monitor and a long-term wrist-monitor, both of which utilize a photoplethysmography-based (PPG) sensor to continuously provide accurate patient readings of 15 health parameters, including cuffless blood pressure, pulse rate, respiratory rate, blood oxygen saturation, temperature, stroke volume, cardiac output, one lead ECG (only chest-monitor) and more. Leveraging its automatic, continuous and noninvasive RPM AI platform, Biobeat has generated the biggest vital-sign database in the world, which it utilizes to identify early deterioration of patients via its proprietary big-data and health-AI tools. Aggregated patient health data is viewed by medical staff via Biobeat's secure HIPPA and GDPR compliant cloud-based patient management platform, which utilizes an automated real-time early warning score (EWS) system that incorporates advanced AI-based algorithms to provide alerts on patient health status and potential deterioration. These capabilities allow Biobeat to support medical teams with tailored patient care such as adjustment of therapeutics and early prevention of specific disease exacerbations. Biobeat's wearable devices are the first devices to be FDA-Cleared for cuffless non-invasive blood pressure monitoring and are also CE Mark certified.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$10M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Biobeat Medical Smart News

2022-04-17 - Judges: Joint winners at INVEST Pitch Perfect's RPM track ...

... a new take on our medical devices pitch track: This year we decided to tweak it to make it Remote Patient Monitoring and Smart Devices.

2022-04-13 - TAU Researchers Advise Smart Sensors To Test COVID-19 ...

Biobeat sensors are approved by the US Food and Drug ... The TAU team wanted the medical-grade sensors to measure those vitals as well as...

2022-04-06 - Innovative technology will use smart sensors to ensure ...

The paper was published in Communications Medicine, a journal from the ... FDA-approved sensors developed by the Israeli company Biobeat.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.5M408%N/A
#2
$4.6M40N/AN/A
#3
$4.6M40-34%N/A
#4
$4.5M40-11%N/A
#5
$8.6M40-15%N/A